pubrio
ArriVent Biopharma

ArriVent Biopharma

United States · Biotechnology Research

Biotechnology Research

ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a deep and global network, ArriVent seeks to access unique and best-in-class drug candidates at various development stages, including those coming from China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, ArriVent aims to globalize medicines for patients with unmet medical need in a broad range of diseases, with an initial focus in oncology.

Company Insights
Company Overview

2020

Founded

Biotechnology Research

Industry

United States

Location

2,609,207

Ranking

71 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding ArriVent Biopharma

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​